AUPH vs CLOV
Aurinia Pharmaceuticals Inc (AUPH) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Aurinia Pharmaceuticals Inc (AUPH) is a biotechnology company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported AUPH revenue for 2024-12-31 was $59.9M. Net income was $1.4M. Revenue was down 11.7% from 2024-09-30 to 2024-12-31. AUPH currently screens at market cap $1.03B and trailing P/E 28.1.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
AUPH currently screens at market cap $1.03B and trailing P/E 28.1. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the AUPH and CLOV stock pages for the full models.
Not investment advice.